中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2015年
22期
26-26,27
,共2页
中晚期肺癌%支气管动脉介入%静脉化疗
中晚期肺癌%支氣管動脈介入%靜脈化療
중만기폐암%지기관동맥개입%정맥화료
Advanced lung cancer%Bronchial artery%Chemotherapy
目的:分析探讨支气管动脉介入治疗与静脉化疗中晚期肺癌的临床疗效。方法选取129例中晚期肺癌患者为研究对象,按照治疗方法将其分为研究组与对照组,介入组70例,化疗组59例。介入组行支气管动脉介入治疗,化疗组行全身静脉化疗,比较两组治疗效果。结果介入组患者治疗总有效率为77.2%,化疗组治疗总有效率为37.2%,介入组患者治疗效果明显高于化疗组(P<0.05),组间比较有统计学意义。结论支气管动脉介入治疗与静脉化疗均可用于肺癌临床治疗中,本次研究结果证实,支气管动脉介入治疗治疗中晚期肺癌更为广泛,可推广应用。
目的:分析探討支氣管動脈介入治療與靜脈化療中晚期肺癌的臨床療效。方法選取129例中晚期肺癌患者為研究對象,按照治療方法將其分為研究組與對照組,介入組70例,化療組59例。介入組行支氣管動脈介入治療,化療組行全身靜脈化療,比較兩組治療效果。結果介入組患者治療總有效率為77.2%,化療組治療總有效率為37.2%,介入組患者治療效果明顯高于化療組(P<0.05),組間比較有統計學意義。結論支氣管動脈介入治療與靜脈化療均可用于肺癌臨床治療中,本次研究結果證實,支氣管動脈介入治療治療中晚期肺癌更為廣汎,可推廣應用。
목적:분석탐토지기관동맥개입치료여정맥화료중만기폐암적림상료효。방법선취129례중만기폐암환자위연구대상,안조치료방법장기분위연구조여대조조,개입조70례,화료조59례。개입조행지기관동맥개입치료,화료조행전신정맥화료,비교량조치료효과。결과개입조환자치료총유효솔위77.2%,화료조치료총유효솔위37.2%,개입조환자치료효과명현고우화료조(P<0.05),조간비교유통계학의의。결론지기관동맥개입치료여정맥화료균가용우폐암림상치료중,본차연구결과증실,지기관동맥개입치료치료중만기폐암경위엄범,가추엄응용。
Objective To analyze the clinical effect of interventional therapy and intravenous chemotherapy in advanced lung cancer bronchial artery. Methods 129 cases of advanced lung cancer patients as the research object, according to the methods of treatment were divided into the study group and control group, 70 cases in the intervention group, chemotherapy group and 59 cases in the intervention group, bronchial artery interventional therapy, and chemotherapy group received systemic chemotherapy, the treatment effects were compared between the two groups. Results The interventional treatment in patients with the total effective rate was 77.2%in the treatment group, the total effective rate was 37.2%, the intervention group was signiifcantly higher than the chemotherapy treatment group (P<0.05), there was signiifcant difference between group. Conclusion Bronchial artery interventional therapy and intravenous chemotherapy can be used for clinical treatment of lung cancer, the results of this study conifrm, bronchial artery interventional therapy in the treatment of advanced lung cancer is more extensive, and can be popularized and applied.